Drug-Resistant Tuberculosis:

Efforts to curb drug-resistant TB must focus on faster diagnostics and effective second-line therapies. Global surveillance and containment strategies are paramount to stopping its spread. Addressing MDR-TB and XDR-TB requires substantial investment in patient-centered approaches and innovative drug formulations.

    Related Conference of Drug-Resistant Tuberculosis:

    April 23-24, 2026

    14th Annual Congress on Pulmonary and Critical Care

    Paris, France
    April 27-28, 2026

    2nd World Congress on Pathology and Laboratory Medicine

    Paris, Aland Islands
    June 11-12, 2026

    5th World Summit on COPD

    Rome, Italy

    Drug-Resistant Tuberculosis: Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in